Literature DB >> 12384089

Dynorphin modulates ocular hydrodynamics and releases atrial natriuretic peptide via activation of kappa-Opioid receptors.

Karen R M Russell1, David E Potter.   

Abstract

The present study was designed to investigate the effect of the kappa opioid receptor (KOR) agonist, dynorphin A (Dyn), on aqueous humor dynamics (intraocular pressure (IOP), aqueous humor flow rate (AFR)), pupil diameter (PD) and atrial natriuretic peptide (ANP) levels in the aqueous humor of the rabbit. Topical and unilateral application of Dyn caused dose-related, bilateral reductions in IOP and AFR. An intermediate dose of Dyn (33 microg) caused bilateral mydriasis whereas a higher dose (100 microg) caused unilateral miosis. The Dyn-induced reduction in IOP and aqueous flow rate as well as the mydriasis were antagonized by nor-binaltorphimine (nor-BNI), a relatively selective KOR antagonist. In addition to the effects on IOP, PD and AFR, Dyn caused dose-related increases in aqueous ANP levels that was attenuated by nor-BNI. The present study indicates that Dyn reduces IOP, in part, by reducing AFR. Moreover, the increase in ANP levels could be involved in the Dyn-induced reductions in IOP and AFR. Based upon the inhibitory effects of nor-BNI, these Dyn-induced events are due, in part, to the activation of KORs in the ciliary processes of the eye.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384089

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  6 in total

Review 1.  Delta Opioids: Neuroprotective Roles in Preclinical Studies.

Authors:  Shahid Husain
Journal:  J Ocul Pharmacol Ther       Date:  2018 Jan/Feb       Impact factor: 2.671

2.  Kappa opioid receptor localization and coupling to nitric oxide production in cells of the anterior chamber.

Authors:  Karen R Russell-Randall; Juanita Dortch-Carnes
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-13       Impact factor: 4.799

3.  Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine.

Authors:  Carol A Rasmussen; B'Ann True Gabelt; Paul L Kaufman
Journal:  Trans Am Ophthalmol Soc       Date:  2007

4.  Morphine-induced nitric oxide production in isolated, iris-ciliary bodies.

Authors:  Juanita Dortch-Carnes; Karen Russell Randall
Journal:  Exp Eye Res       Date:  2009-06-23       Impact factor: 3.467

5.  Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human.

Authors:  Linda M Rorick-Kehn; Jennifer W Witcher; Stephen L Lowe; Celedon R Gonzales; Mary Ann Weller; Robert L Bell; John C Hart; Anne B Need; Jamie H McKinzie; Michael A Statnick; Jeffrey G Suico; David L McKinzie; Sitra Tauscher-Wisniewski; Charles H Mitch; Randall R Stoltz; Conrad J Wong
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

6.  Influence of the hypothalamic arcuate nucleus on intraocular pressure and the role of opioid peptides.

Authors:  Ji Jin; Guo-xu Xu; Zhi-lan Yuan
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.